AT95424T

Site-directed mutagenesis modified glycoprotein hormones and methods of use

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

20 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
Document	Office	Kind	Date
13623687	United States of America	A	1987-12-21

Members20

Family members, oldest first
Document	Office	Kind
EP0322226A2	European Patent Office (EPO)	A2	1989-06-28
JPH022384A	Japan	A	1990-01-08
EP0322226A3	European Patent Office (EPO)	A3	1990-06-13
EP0322226B1	European Patent Office (EPO)	B1	1993-10-06
AT95424TThis record	Austria	T	1993-10-15
US5260421A	United States of America	A	1993-11-09
DE3884776D1	Germany	D1	1993-11-11
DE3884776T2	Germany	T2	1994-02-10
US5352779A	United States of America	A	1994-10-04
ES2059545T3	Spain	T3	1994-11-16
HK143395A	Hong Kong, China	A	1995-09-15
JP2525048B2	Japan	B2	1996-08-14
US5635475A	United States of America	A	1997-06-03
US5705479A	United States of America	A	1998-01-06
EP0322226B2	European Patent Office (EPO)	B2	1999-11-10
US5986068A	United States of America	A	1999-11-16
GR3032307T3	Greece	T3	2000-04-27
ES2059545T5	Spain	T5	2000-05-01
DE3884776T3	Germany	T3	2000-06-21
CA1341284C	Canada	C	2001-08-14

3 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2009-03-15	Cancelled due to lapse of timeLapsedEELA	EELA
2000-07-15	Publication of translation of european patent specificationUEP	UEP
1994-06-15	Publication of translation of european patent specificationUEP	UEP